722 related articles for article (PubMed ID: 23934982)
41. Treatment for peritoneal dialysis-associated peritonitis.
Ballinger AE; Palmer SC; Wiggins KJ; Craig JC; Johnson DW; Cross NB; Strippoli GF
Cochrane Database Syst Rev; 2014 Apr; (4):CD005284. PubMed ID: 24771351
[TBL] [Abstract][Full Text] [Related]
42. Pregabalin for chronic prostatitis.
Aboumarzouk OM; Nelson RL
Cochrane Database Syst Rev; 2012 Aug; (8):CD009063. PubMed ID: 22895982
[TBL] [Abstract][Full Text] [Related]
43. Prulifloxacin: a review focusing on its use beyond respiratory and urinary tract infections.
Rafailidis PI; Polyzos KA; Sgouros K; Falagas ME
Int J Antimicrob Agents; 2011 Apr; 37(4):283-90. PubMed ID: 21300527
[TBL] [Abstract][Full Text] [Related]
44. A switch therapy protocol with intravenous azithromycin and ciprofloxacin combination for severe, relapsing chronic bacterial prostatitis: a prospective non-comparative pilot study.
Kolumbić Lakos A; Skerk V; Maleković G; Dujnić Spoljarević T; Kovacic D; Pasini M; Markotić A; Magri V; Perletti G
J Chemother; 2011 Dec; 23(6):350-3. PubMed ID: 22233819
[TBL] [Abstract][Full Text] [Related]
45. Azithromycin versus doxycycline for the treatment of genital chlamydia infection: a meta-analysis of randomized controlled trials.
Kong FY; Tabrizi SN; Law M; Vodstrcil LA; Chen M; Fairley CK; Guy R; Bradshaw C; Hocking JS
Clin Infect Dis; 2014 Jul; 59(2):193-205. PubMed ID: 24729507
[TBL] [Abstract][Full Text] [Related]
46. Antibiotic activity and concentrations in clinical samples from patients with chronic bacterial prostatitis.
Heras-Cañas V; Gutiérrez-Soto B; Almonte-Fernández H; Lara-Oya A; Navarro-Marí JM; Garrido-Frenich A; Vázquez-Alonso F; Gutiérrez-Fernández J
Actas Urol Esp; 2017 Dec; 41(10):631-638. PubMed ID: 28641870
[TBL] [Abstract][Full Text] [Related]
47. Fluoroquinolones for treating tuberculosis.
Ziganshina LE; Squire SB
Cochrane Database Syst Rev; 2008 Jan; (1):CD004795. PubMed ID: 18254061
[TBL] [Abstract][Full Text] [Related]
48. Antimicrobial treatment of prostatitis.
Wagenlehner FM; Naber KG
Expert Rev Anti Infect Ther; 2003 Aug; 1(2):275-82. PubMed ID: 15482123
[TBL] [Abstract][Full Text] [Related]
49. Bacterial prostatitis.
Wagenlehner FM; Pilatz A; Bschleipfer T; Diemer T; Linn T; Meinhardt A; Schagdarsurengin U; Dansranjavin T; Schuppe HC; Weidner W
World J Urol; 2013 Aug; 31(4):711-6. PubMed ID: 23519458
[TBL] [Abstract][Full Text] [Related]
50. Allopurinol for chronic prostatitis.
McNaughton CO; Wilt T
Cochrane Database Syst Rev; 2002; (4):CD001041. PubMed ID: 12519549
[TBL] [Abstract][Full Text] [Related]
51. Use of antibiotics in chronic prostatitis syndromes.
Shoskes DA
Can J Urol; 2001 Jun; 8 Suppl 1():24-8. PubMed ID: 11442994
[TBL] [Abstract][Full Text] [Related]
52. Clinical and Microbiological Features and Factors Associated with Fluoroquinolone Resistance in Men with Community-Acquired Acute Bacterial Prostatitis.
Park MG; Cho MC; Cho SY; Lee JW
Urol Int; 2016; 96(4):443-8. PubMed ID: 26943143
[TBL] [Abstract][Full Text] [Related]
53. Antimicrobial therapy for bacterial and nonbacterial prostatitis.
Fowler JE
Urology; 2002 Dec; 60(6 Suppl):24-6; discussion 26. PubMed ID: 12521585
[TBL] [Abstract][Full Text] [Related]
54. Synergistic effect between catechin and ciprofloxacin on chronic bacterial prostatitis rat model.
Lee YS; Han CH; Kang SH; Lee SJ; Kim SW; Shin OR; Sim YC; Lee SJ; Cho YH
Int J Urol; 2005 Apr; 12(4):383-9. PubMed ID: 15948727
[TBL] [Abstract][Full Text] [Related]
55. Role of prulifloxacin in the treatment of acute rhinosinusitis.
Passali D; Crisanti A; Bellussi LM
Infez Med; 2015 Dec; 23(4):301-6. PubMed ID: 26700078
[TBL] [Abstract][Full Text] [Related]
56. Oral fosfomycin for the treatment of chronic bacterial prostatitis.
Karaiskos I; Galani L; Sakka V; Gkoufa A; Sopilidis O; Chalikopoulos D; Alivizatos G; Giamarellou E
J Antimicrob Chemother; 2019 May; 74(5):1430-1437. PubMed ID: 30796442
[TBL] [Abstract][Full Text] [Related]
57. Cefoxitin-based antibiotic therapy for extended-spectrum β-lactamase-producing Enterobacteriaceae prostatitis: a prospective pilot study.
Demonchy E; Courjon J; Ughetto E; Durand M; Risso K; Garraffo R; Roger PM
Int J Antimicrob Agents; 2018 Jun; 51(6):836-841. PubMed ID: 29378342
[TBL] [Abstract][Full Text] [Related]
58. Safety and efficacy of levofloxacin versus ciprofloxacin for the treatment of chronic bacterial prostatitis in Chinese patients.
Zhang ZC; Jin FS; Liu DM; Shen ZJ; Sun YH; Guo YL
Asian J Androl; 2012 Nov; 14(6):870-4. PubMed ID: 22864282
[TBL] [Abstract][Full Text] [Related]
59. Assessment of the UTI criteria for bacterial prostatitis in Japan.
Arakawa S; Kamidono S
Infection; 1992; 20 Suppl 3():S232-4. PubMed ID: 1337062
[TBL] [Abstract][Full Text] [Related]
60. Fluoroquinolones or macrolides alone versus combined with β-lactams for adults with community-acquired pneumonia: Systematic review and meta-analysis.
Raz-Pasteur A; Shasha D; Paul M
Int J Antimicrob Agents; 2015 Sep; 46(3):242-8. PubMed ID: 26092096
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
